FEI Tribunal issues Final Decision

The FEI Tribunal has issued its Final Decision in a case involving Ergonovine, a *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

Uruguayan Endurance athlete Victoria Goñi (FEI ID 10042167) has been suspended for two years following the adverse analytical finding in samples taken from the horse El Mate (FEI ID 104XI43/URU) at the CEI2* 120 in Trinidad (URU) on 4 February 2017.

The athlete has been provisionally suspended since 5 April 2017, the date of notification of the positive result and, following the Final Decision, the period of ineligibility will run through to 4 April 2019.

The athlete has also been fined 3,000 CHF and will contribute 1,500 CHF towards the cost of the judicial procedure.

The Decision can be appealed before the Court of Arbitration for Sport within 21 days from the date the decision was rendered/notified (7 June 2017).

The full text of the FEI Tribunal’s Final Decision on this case can be viewed here.

Notes to Editors:

FEI Prohibited Substances

The FEI’s Prohibited Substances List is divided into two sections - Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition.

Banned (doping) Substances should never be found in the body of the horse. In the case of an adverse analytical finding for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification. The horse is suspended for two months.